• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sertraline 50 mg daily: the optimal dose in the treatment of depression.

作者信息

Preskorn S H, Lane R M

机构信息

Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Wichita 67214, USA.

出版信息

Int Clin Psychopharmacol. 1995 Sep;10(3):129-41. doi: 10.1097/00004850-199510030-00001.

DOI:10.1097/00004850-199510030-00001
PMID:8675965
Abstract

The dose regimen for sertraline in the treatment of depression has been well established. The starting dose, 50 mg/day, is the usually effective therapeutic dose, and the optimal dose when considering both efficacy and tolerability for most patients. For patients who do not show an adequate therapeutic response within 24 weeks, the dose of sertraline can be increased in 50 mg/day increments at no less than weekly intervals to a maximum of 200 mg/day. Sertraline is generally given as a single daily dose and may be administered at any time of the day. In contrast to other selective serotonin reuptake inhibitors, there is no need for altered dose recommendations in the elderly.

摘要

相似文献

1
Sertraline 50 mg daily: the optimal dose in the treatment of depression.
Int Clin Psychopharmacol. 1995 Sep;10(3):129-41. doi: 10.1097/00004850-199510030-00001.
2
Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.舍曲林。对其药效学和药代动力学特性以及在抑郁症和强迫症中的治疗潜力的综述。
Drugs. 1992 Oct;44(4):604-24. doi: 10.2165/00003495-199244040-00007.
3
Sertraline for the treatment of depression in Parkinson's disease.
Mov Disord. 1997 Sep;12(5):756-9. doi: 10.1002/mds.870120522.
4
Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?对一种5-羟色胺选择性再摄取抑制剂不耐受的患者对另一种也不耐受吗?
J Clin Psychiatry. 1995 Jan;56(1):30-4.
5
Sertraline and breast-feeding.
N Engl J Med. 1997 Apr 17;336(16):1189-90. doi: 10.1056/NEJM199704173361615.
6
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.舍曲林与帕罗西汀治疗妄想性抑郁症的双盲对照试验。
Am J Psychiatry. 1996 Dec;153(12):1631-3. doi: 10.1176/ajp.153.12.1631.
7
Sertraline in social phobia.舍曲林治疗社交恐惧症。
Anxiety. 1994;1(4):196-8. doi: 10.1002/anxi.3070010409.
8
Sertraline: a new antidepressant.
Am Fam Physician. 1993 Aug;48(2):311-4.
9
[The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].[临床药理学案例(5)。5-羟色胺再摄取抑制剂与5-羟色胺3受体拮抗剂:是否存在临床相关相互作用?]
Praxis (Bern 1994). 1996 Nov 12;85(46):1490-2.
10
Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome.舍曲林,一种选择性5-羟色胺再摄取抑制剂,引发类癌综合征。
Am J Gastroenterol. 1997 Aug;92(8):1387-8.

引用本文的文献

1
Folic Acid Mitigates Sertraline-Induced Liver Damage in Adult Female Albino Rats During Pregnancy and Postpartum: A Biochemical and Histological Study.叶酸减轻成年雌性白化大鼠孕期和产后舍曲林诱导的肝损伤:一项生化和组织学研究
Medicina (Kaunas). 2025 Apr 18;61(4):751. doi: 10.3390/medicina61040751.
2
Diagnostic psychiatric and somatic comorbidity in patients with depression in the Western Balkan countries.在西巴尔干国家,抑郁症患者的诊断性精神和躯体共病情况。
PLoS One. 2024 Jan 2;19(1):e0295754. doi: 10.1371/journal.pone.0295754. eCollection 2024.
3
Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis.
选择性5-羟色胺再摄取抑制剂单药治疗抑郁症的剂量-反应效应:综述的系统评价与元叙事综合分析
BMJ Med. 2022 Dec 1;1(1):e000017. doi: 10.1136/bmjmed-2021-000017. eCollection 2022.
4
A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects.一项评估超高治疗剂量舍曲林对健康受试者心脏复极影响的全面 QT 研究。
Clin Pharmacol Drug Dev. 2020 Apr;9(3):307-320. doi: 10.1002/cpdd.749. Epub 2019 Nov 27.
5
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors.一项针对固定剂量试验的荟萃分析揭示了三种选择性5-羟色胺再摄取抑制剂抗抑郁作用的剂量依赖性及快速起效特性。
Transl Psychiatry. 2016 Jun 7;6(6):e834. doi: 10.1038/tp.2016.104.
6
Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.舍曲林单药治疗及联合加巴喷丁对近期戒断的伴有抑郁症状的可卡因依赖患者的临床疗效。
J Clin Psychopharmacol. 2014 Apr;34(2):234-9. doi: 10.1097/JCP.0000000000000062.
7
Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.舍曲林可延迟有抑郁症状的近期戒断可卡因依赖患者的复发。
Addiction. 2012 Jan;107(1):131-41. doi: 10.1111/j.1360-0443.2011.03552.x. Epub 2011 Oct 10.
8
The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies.血清素能神经传递增加对攻击行为的影响:临床前研究的批判性荟萃分析综述
Psychopharmacology (Berl). 2009 Aug;205(3):349-68. doi: 10.1007/s00213-009-1543-2. Epub 2009 Apr 30.
9
Selective serotonin reuptake inhibitor use in primary care: a 5-year naturalistic study.选择性 5-羟色胺再摄取抑制剂在初级保健中的应用:一项为期 5 年的自然主义研究。
Clin Drug Investig. 1998;16(6):453-62. doi: 10.2165/00044011-199816060-00005.
10
Clinical pharmacokinetics of darunavir.达芦那韦的临床药代动力学。
Clin Pharmacokinet. 2007;46(9):739-56. doi: 10.2165/00003088-200746090-00002.